Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism

British Journal of Pharmacology

Volumn 130, Issue 2, 2000, Pages 289-298

  Croxtall, Jamie D ^a   Choudhury, Qam ^a   Flower, Rod J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

A549 cells; Annexin 1; Epidermal growth factor; Epidermal growth factor receptors; Glucocorticoids; Grb2; Lipocortin 1; Mitogen activated protein kinase

Indexed keywords

ARACHIDONIC ACID; DACTINOMYCIN; DEXAMETHASONE; EPIDERMAL GROWTH FACTOR RECEPTOR; GLUCOCORTICOID; GROWTH FACTOR RECEPTOR; MIFEPRISTONE; MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDE; PHOSPHOLIPASE A2; PHOSPHOPROTEIN; PROTEIN P21; PROTEIN TYROSINE KINASE; RAF PROTEIN; SERINE;

ADENOCARCINOMA; AMINO TERMINAL SEQUENCE; ARTICLE; CELL MEMBRANE TRANSPORT; ENZYME PHOSPHORYLATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANNEXIN A1; BINDING, COMPETITIVE; DEXAMETHASONE; ENZYME ACTIVATION; GLUCOCORTICOIDS; GRB2 ADAPTOR PROTEIN; HUMANS; MAP KINASE SIGNALING SYSTEM; PHOSPHOLIPASES A; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0034059188     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703272     Document Type: Article

References (42)

1. AHN, N.G., SEGER, R., BRATLIEN, R.L., DILTZ, C.D., TONKS, N.K. & E.G. KREBS. (1991). Multiple components in an epidermal growth factor-stimulated protein kinase cascade. J. Biol. Chem., 266, 4220-4227.
2. BAMBERGER, C.M., SCHULTE, H.M. & CHROUSOS, G.P. (1996). Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocrin. Rev., 17, 245-261.
3. BOST, F., MCKAY, R., DEAN, N. & MERCOLA, D. (1997). The JUN kinase/stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells. J. Biol. Chem., 272, 33422-33429.
4. BUCKINGHAM, J.C. (1996). Stress and the neuroendocrine-immune axis: the pivotal role of glucocorticoids and lipocortin 1. Br. J. Pharmacol., 118, 1-19.
5. BUDAY, L., EGAN, S.E., VICIANA, P.R., CANTRELL, D.A. & DOWNWARD, J. (1994). A complex of Grb2 adaptor protein, Sos exchange factor, and a 36-kDa membrane-bound tyrosine phosphoprotein is implicated in Ras activation in T cells. J. Biol. Chem., 269, 9019-9023.
6. CAELLES, C., GONZALEZ-SANCHO, J. & MUNOZ, A. (1997). Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway. Genes Dev., 11, 3351-3364.
7. CROXTALL, J.D., CHOUDHURY, Q. & FLOWER, R.J. (1998). Inhibitory effect of peptides derived from the N-terminus of lipocortin 1 on arachidonic acid release and proliferation in the A549 cell line: identification of E-Q-E-Y-V as a crucial component. Br. J. Pharmacol., 123, 975-983.
8. 2 activity in A549 cells. Biochem. Pharmacol., 52, 351-356.
9. CROXTALL, J.D., CHOUDHURY, Q., TOKUMOTO, H. & FLOWER, R.J. (1995). Lipocortin 1 and the control of arachidonic acid release in cell signalling. Biochem. Pharmacol., 50, 465-474.
10. CROXTALL, J.D. & FLOWER, R.J. (1992). Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line. Proc. Natl. Acad. Sci. U.S.A., 89, 3571-3575.
11. CROXTALL, J.D. & FLOWER, R.J. (1994). Antisense oligonucleotides to human lipocortin-1 inhibit glucocorticoid-induced inhibition of A549 cell growth and eicosanoid release. Biochem. Pharmacol., 48, 1729-1734.
12. CROXTALL, J.D., WAHEED, S., CHOUDHURY, Q., ANAND, R. & FLOWER, R.J. (1993). N-terminal peptide fragments of lipocortin-1 inhibit A549 cell growth and block EGF-induced stimulation of proliferation. Int. J. Cancer, 54, 153-158.
13. DALMAN, F.C., SCHERRER, L.C., TAYLOR, L.P., AKIL, H. & PRATT, W.B. (1991). Localization of the 90 kDa heat shock protein binding site within the hormone binding domain of the glucocorticoid receptor by peptide competition. J. Biol. Chem., 266, 3482-3490.
14. ras in activation of extracellular signal-related kinase 2. Nature, 357, 602-604.
15. γ1-binding phosphotyrosyl protein pp36/38. J. Biol. Chem., 270, 20177-20182.
16. FURET, P., GAY, B., CARAVATTI, G., GARCIA-ECHEVERRIA, C., RAHUEL, J., SCHOEPFER, J. & FRETZ, H. (1998). Structure-based design and synthesis of high affinity tripeptide ligands of the Grb2-SH2 domain. J. Med. Chem., 41, 3442-3449.
17. GALIGNIANA, M.D., SCRUGGS, J.L., HERRINGTON, J., WELSH, M.J., CARTER-SU, C., HOUSLEY, P.R. & PRATT, W.B. (1998). Heat shock protein90-dependent (geldanamycin-inhibited) movement of the glucocorticoid receptor through the cytoplasm to the nucleus requires intact cytoskeleton. Mol. Endocrinol., 12, 1903-1913.
18. GOULDING, N.J., PAN, L., K. WARDWELL, K., GUYRE, V.C. & GUYRE, P.M. (1996). Evidence for specific annexin I-binding proteins on human monocytes. Biochem. J., 316, 593-597.
19. HANKE, J.H., GARDNER, J.P., DOW, R.L., CHANGELIAN, P.S., BRISSETTE, W.H., WERINGER, E.J., POLLOK, B.A. & CONNELLY, P.A. (1996). Discovery of a novel, potent, and src-family-selective tyrosine kinase inhibitor: study of Lck-and Fyn-dependent T cell activation. J. Biol. Chem., 271, 695-701.
20. HECK, S., KULLMANN, M., GAST, A., PONTA, H., RAHMSDORF, H.J., HERRLICH, P. & CATO, A.C.B. (1994). A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J., 13, 4087-4095.
21. γ1, Grb2, and phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. U.S.A., 92, 11618-11622.
22. JELINEK, T., CATLING, A.D., RUETER, C.M.W., MOODIE, S.A., WOLFMAN, A. & WEBER, M.J. (1994). RAS and RAF-1 form a signalling complex with MEK-1 but not MEK-2. Mol. Cell. Biol., 14, 8212-8218.
23. KARASIK, A., PEPINSKY, R.B., SHOELSON, S.E. & KAHN, C.R. (1988). Lipocortins 1 and 2 as substrates for the insulin receptor kinase in rat liver. J. Biol. Chem., 263, 11862-11867.
24. KEMPPANIEN, R.J. & BEHREND, E.N. (1998). Dexamethasone rapidly induces a novel ras superfamily member-related gene in AtT-20 cells. J. Biol. Chem., 273, 3129-3131.
25. 2 is phosphorylated and activated by MAP kinase. Cell, 72, 269-278.
26. MELKI, V., HULLIN, F., MAZARGUIL, H., FAUVEL, J., RAGAB-THOMAS, J.M.F. & CHAP, H. (1994). Annexin I as a potential inhibitor of insulin receptor tyrosine kinase. Biochem. Biophys. Res. Commun., 203, 813-819.
27. MERRY, W.H., CAPLAN, R.H., WICKUS, G.G., REYNERTSON, R.H., KISKEN, W.A., COGBILL, T.H. & LANDERCASPER, J. (1994). Post operative acute adrenal failure caused by transient corticotropin deficiency. Surgery, 116, 1095-1100.
28. ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J., 15, 1292-1300.
29. OKADA, S., KAO, A.W., CERESA, B.P., BLAIKIE, P., MARGOLIS, B. & PESSIN, J.E. (1997). The 66-kDa She isoform is a negative regulator of the epidermal growth factor-stimulated mitogen-activated protein kinase pathway. J. Biol. Chem., 272, 28042-28049.
30. PEPINSKY, R.B. & SINCLAIR, L.K. (1986). Epidermal growth factor-dependent phosphorylation of lipocortin. Nature, 321, 81-85.
31. PRATT, W.B. (1998). The hsp90-based chaperone system: involvement in signal transduction from a variety of hormone and growth factor receptors. Proc. Soc. Exp. Biol. Med., 217, 420-434.
32. RADKE, K. & MARTIN, G.S. (1979). Transformation by Rous sarcoma virus: effect of src gene expression on the synthesis and phosphorylation of cellular polypeptides. Proc. Natl. Acad. Sci. U.S.A., 76, 5212-5216.
33. REICHARDT, H.M., KAESTNER, K.H., TUCKERMANN, J., KRETZ, O., GASS, P., SCHMID, W., HERRLICH, P., ANGEL, P. & SCHUTZ, G. (1998). DNA binding of the glucocorticoid receptor is not essential for survival. Cell, 93, 531-541.
34. 2+-dependent phospholipid binding and phosphorylation of lipocortin 1. J. Biol. Chem., 262, 6931-6937.
35. SCHLAEPFER, D.D. & HAIGLER, H.T. (1988). In vitro protein kinase C phosphorylation sites of placental lipocortin. Biochemistry, 27, 4253-4258.
36. SKOUTERIS, G.G. & SCHRODER, C.H. (1996). The hepatocyte growth factor receptor kinase-mediated phosphorylation of lipocortin-1 transduces the proliferating signal of the hepatocyte growth factor. J. Biol. Chem., 271, 27266-27273.
37. SMITHGALL, T.E. (1995). SH2 and SH3 domains: potential targets for anti-cancer drug design. J. Pharmacol. Toxicol. Methods, 34, 125-132.
38. 2 activity. Br. J. Pharmacol., 124, 1675-1683.
39. SUMMERS, T.A. & CREUTZ, C.E. (1985). Phosphorylation of a chromaffin granule-binding protein by protein kinase C. J. Biol. Chem., 260, 2437-2443.
40. TUMLIN, J.A., LEA, J.P., SWANSON, C.E., SMITH, C.L., EDGE, S.S. & SOMEREN, J.S. (1997). Aldosterone and dexamethasone stimulate calcineurin activity through a transcription-independent mechanism involving steroid receptor-associated heat shock proteins. J. Clin. Invest., 99, 1217-1223.
41. VISHWANATH, B.S., FREY, F.J., BRADBURY, M.J., DALLMAN, M.F. & FREY, B.M. (1992). Adrenalectomy decreases lipocortin-1 messenger ribonucleic acid and tissue protein content in rats. Endocrinology, 130, 585-591.
42. WHITESELL, L. & COOK, P. (1996). Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells. Mol. Endocrinol., 10, 705-712.